Fig. 7.

MAP2 and NF-L serum levels of patients suffering from stroke at day 1 and day 3 after stroke onset: patients were divided into groups depending on a stroke intervention or b the size of the ischemic lesion. Patients with stroke (with and without intervention) have significantly higher serum concentrations of MAP2 than patients suffering from TIA. Significantly higher MAP2 serum levels are also found in patients suffering from larger infarcts compared to no ischemic lesion. Significant differences between day 1 and day 3 are only found after a lacunar stroke (MAP2 and NF-L). a and b: n=12–30. Bars represent mean values; dots represent individual values; error bars indicate the standard error. *p<0.05, **p<0.01, ***p<0.001